Patent ID: 11858910
Assignee: SUNSHINE LAKE PHARMA CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC C

Claim 14:
15. The method of claim 14, wherein the 5-HT1F receptor-related disease is migraine, general pain, trigeminal neuralgia, dental pain or temperomandibular joint dysfunction pain, autism, obsession, phobia, depression, social phobia, anxiety, general anxiety disorder, disorders of sleep, post-traumatic syndrome, chronic fatigue syndrome, premenstrual syndrome or late luteal phase syndrome, borderline personality disorder, disruptive behavior disorders, impulse control disorders, attention deficit hyperactivity disorder, alcoholism, tobacco abuse, mutism, trichotillomania, bulimia, anorexia nervosa, premature ejaculation, erectile dysfunction, memory loss or dementia.